Metabolic abnormalities and oxidative stress in lupus
Authors:
- Luz P. BlancoLBLuz P. Blanco
- Mariana J. KaplanMKMariana J. Kaplan
- 1 September 2017
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 29 (5) , 442-449
Abstract
Purpose of review: Upon antigen exposure, immune cells rely on cell-specific metabolic pathways to mount an efficient immune response. In autoimmunity, failure in critical metabolic checkpoints may lead to immune cell hyperactivation and tissue damage. Oxidative stress in autoimmune patients can also contribute to immune dysregulation and injury to the host. Recent insights into the immune cell metabolism signatures, specifically associated with systemic lupus erythematosus (SLE) and the consequences of heightened oxidative stress in patients, are discussed herein.Recent findings: Glucose metabolism inhibitors, mechanistic target of rapamycin pathway modulators, and peroxisome proliferator-activated receptor gamma-activating compounds demonstrate therapeutic benefit in experimental models of lupus. Mitochondrial-derived reactive oxygen species (ROS) and molecular modifications induced by oxidative stress appear to be detrimental in lupus. Effective therapies tailored toward the reconfiguration of metabolic imbalances in lupus immune cells and the reduction of mitochondrial ROS production/availability are currently being tested.Summary: A paucity of knowledge exists regarding the metabolic needs of a number of immune cells involved in the pathogenesis of SLE, including myeloid cells and B cells. Nonetheless, SLE-specific metabolic signatures have been identified and their specific targeting, along with mitochondrial ROS inhibitors/scavengers, could show therapeutic advantage in lupus patients.Keywords
This publication has 85 references indexed in Scilit:
- Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrierProceedings of the National Academy of Sciences, 2013
- Metabolic Disturbances Associated with Systemic Lupus ErythematosusPLOS ONE, 2012
- The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte ActivationImmunity, 2011
- Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiationProceedings of the National Academy of Sciences, 2011
- Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA–Peptide Complexes in Systemic Lupus ErythematosusScience Translational Medicine, 2011
- Markers of oxidative and nitrosative stress in systemic lupus erythematosus: Correlation with disease activityArthritis & Rheumatism, 2010
- A Distinct Subset of Proinflammatory Neutrophils Isolated from Patients with Systemic Lupus Erythematosus Induces Vascular Damage and Synthesizes Type I IFNsThe Journal of Immunology, 2010
- The Peroxisome Proliferator-Activated Receptor γ Agonist Pioglitazone Improves Cardiometabolic Risk and Renal Inflammation in Murine LupusThe Journal of Immunology, 2009
- Rapamycin reduces disease activity and normalizes T cell activation–induced calcium fluxing in patients with systemic lupus erythematosusArthritis & Rheumatism, 2006
- Functional characterization of mitochondria in neutrophils: a role restricted to apoptosisCell Death & Differentiation, 2003